Diagnostic Kit for Isoenzyme MB of Creatine Kinase(fluorescence immunochromatographic assay)

inkcazelo emfutshane:


  • Ixesha lovavanyo:Imizuzu eyi-10-15
  • Ixesha elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:1/25 uvavanyo / ibhokisi
  • Ubushushu bokugcina :2℃-30℃
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    I-Diagnostic Kit ye-Isoenzyme MB ye-Creatine Kinase(uvavanyo lwe-fluorescence immunochromatographic)
    Ukusetyenziswa kwe-in vitro diagnostic kuphela

    Nceda ufunde le phakheji ifake ngononophelo phambi kokuba uyisebenzise kwaye ulandele ngokungqongqo imiyalelo. Ukuthembeka kweziphumo zovavanyo akunakuqinisekiswa ukuba kukho nakuphi na ukutenxa kwimiyalelo ekweli phakheji.

    UKUSETYENZISWA OKUHLOSIWEYO
    Diagnostic Kit for Isoenzyme MB of Creatine Kinase(fluorescence immunochromatographic assay) luvavanyo lwe-fluorescence immunochromatographic yobhaqo lomyinge we-Isoenzyme MB ye-Creatine Kinase (CK-MB) kwiserum yomntu okanye kwiplasma, isetyenziselwa ukuxilongwa kwe-AMI ecute (Acute Myocardial). Infarction). Zonke iisampuli ezilungileyo kufuneka ziqinisekiswe ngezinye iindlela. Olu vavanyo lwenzelwe ukusetyenziswa kweengcali zezempilo kuphela.

    USHWANKATHELO
    Amanqanaba e-CK-MB anda kwiiyure ze-4-6 emva kokuba i-Myocardial infarction yenzeke, iphakamileyo kwiiyure ze-18-24, kwaye ibuyele kwisiqhelo se-2-3 iintsuku kamva. Ukukhutshwa kwe-CK-MB kujikelezo emva kwehemoglobin.CK-MB luphawu lwemveli lwe-acute myocardial infarction

    UMGAQO WENKQUBO
    Inwebu yesixhobo sovavanyo igqunywe nge-anti-CK-MB ye-antibody kwindawo yovavanyo kunye ne-antibody ye-IgG yebhokhwe kwindawo yolawulo. Iphedi elayibhile iqatywe nge-fluorescence ebhalwe i-anti-CK-MB ye-antibody kunye ne-IgG yomvundla kwangaphambili. Xa uvavanyo lwesampulu eqinisekileyo, i-antigen ye-CK-MB kwisampulu idibanisa ne-fluorescence ebhalwe i-antibody ye-CK-MB, kwaye yenze umxube wokuzivikela komzimba. Ngaphantsi kwesenzo se-immunochromatography, ukuhamba okuyinkimbinkimbi kwicala lephepha elifunxayo, xa i-complex idlula ummandla wokuvavanya, idibene ne-anti-CK-MB yokugquma i-antibody, yenza i-complex entsha. Inqanaba le-CK-MB linxulunyaniswe kakuhle nomqondiso we-fluorescence, kwaye ukuxinwa kwe-CK-MB kwisampulu kunokubonwa ngovavanyo lwe-fluorescence immunoassay.

    IIREGENTS KUNYE NEZINTO EZIBONISWAYO

    Amacandelo ephakheji ye-25T:
    Ikhadi lokuvavanya ifoyile nganye efakwe kwi-desiccant 25T
    Isampulu yediluyinti 25T
    Faka ipakethi 1

    IZINTO EZIFUNEKAYO KODWA AKUNIKEZWA
    Isampulu yokuqokelela isitya,ixesha

    UKUQOKELELWA KWEsampuli NOKUGCINWA
    1.Iisampulu ezivavanyiweyo zingaba serum, i-heparin anticoagulant plasma okanye i-EDTA anticoagulant plasma.

    2.Ngokungqinelana neendlela eziqhelekileyo zokuqokelela isampuli. I-Serum okanye isampuli ye-plasma inokugcinwa efrijini kwi-2-8 ℃ ye-7days kunye ne-cryopreservation engaphantsi kwe-15 ° C kwiinyanga ezi-6.
    3.Zonke iisampulu ziphephe imijikelo yokunyibilika komkhenkce.

    INKQUBO YOVAVANYO
    Nceda ufunde incwadi yokusebenza kwesixhobo kunye nokufakwa kwephakheji phambi kovavanyo.

    I-1.Lay eceleni zonke ii-reagents kunye neesampuli kwiqondo lokushisa.
    2.Vula i-Portable Immune Analyzer (WIZ-A101), faka igama lokungena kwi-akhawunti ngokwendlela yokusebenza yesixhobo, kwaye ungenise ujongano lokubona.
    3.Skena ikhowudi yokuchaza ukuze uqinisekise into yovavanyo.
    4.Khupha ikhadi lovavanyo kwibhegi yefoyile.
    5.Faka ikhadi lovavanyo kwi-slot yekhadi, scan ikhowudi ye-QR, kwaye unqume into yovavanyo.
    5.Yongeza i-40μL ye-serum okanye isampuli yeplasma kwisampulu ye-diluent, kwaye udibanise kakuhle.
    6.Yongeza 80μL isampulu isisombululo kwisampulu kakuhle ikhadi.
    7.Cofa iqhosha elithi "standard test", emva kwemizuzu eyi-15, isixhobo siya kubona ngokuzenzekelayo ikhadi lovavanyo, sinokufunda iziphumo kwisikrini sokubonisa isixhobo, kwaye sirekhode / siprinte iziphumo zovavanyo.
    8.Jonga kumyalelo we-Portable Immune Analyzer (WIZ-A101).

    IINDLELA EZILINDELEKILEYO
    CK-MB <5ng/mL

    Kucetyiswa ukuba ilabhoratri nganye iseke uluhlu lwayo oluqhelekileyo olumele izigulane zayo.

    IZIPHUMO ZOMVAVANYO KUNYE UTOLIKO
    .Le datha ingentla isiphumo sovavanyo lwe-reagent ye-CK-MB, kwaye kucetyiswa ukuba ilabhoratri nganye kufuneka iseke uluhlu lwamaxabiso okubona i-CK-MB alungele abemi kulo mmandla. Ezi ziphumo zingentla zezereferensi kuphela.

    .Iziphumo zale ndlela zisebenza kuphela kuluhlu lwereferensi olusekwe kule ndlela, kwaye akukho kuthelekiswa ngokuthe ngqo kunye nezinye iindlela.
    .Ezinye izinto zinokubangela iimpazamo kwiziphumo zokubona, kubandakanywa nezizathu zobugcisa, iimpazamo zokusebenza kunye nezinye izinto zesampulu.

    UKUGCINWA NOZINZI
    1.Ikhithi ziinyanga ezili-18 zobomi beshelufa ukusukela kumhla wokwenziwa. Gcina iikhithi ezingasetyenziswanga kwi-2-30°C. MUSA UKUMKHENZA. Musa ukusebenzisa ngaphaya komhla wokuphelelwa.

    2.Musa ukuvula isingxobo esitywiniweyo de ube ulungele ukwenza uvavanyo, kwaye uvavanyo lokusetyenziswa olunye lucetyiswa ukuba lusetyenziswe phantsi kwendawo efunekayo (iqondo lobushushu 2-35℃, ukufuma 40-90%) ngaphakathi kwemizuzu engama-60 ngokukhawuleza. kangangoko kunokwenzeka.
    I-3.I-diluent yesampuli isetyenziswa ngokukhawuleza emva kokuvulwa.

    IZILUMKISO NEMIGAQO
    .Ikhithi kufuneka itywinwe kwaye ikhuselwe kumswakama.

    .Yonke imizekelo emihle iya kuqinisekiswa ngezinye iindlela.
    .Yonke imizekelo iya kuphathwa njengongcoliseko olunokubakho.
    .USUKU sebenzisa i-reagent ephelelwe lixesha.
    . MUSA ukutshintshanisa iirejenti phakathi kweekhithi ezineqashiso ezahlukeneyo No..
    .USUKU phinda usebenzise amakhadi ovavanyo kunye naziphi na izincedisi ezilahlwayo.
    .I-Misoperation, isampuli eninzi okanye encinci inokukhokelela ekuphambukeni kweziphumo.

    LUKUXELELA
    .Njengalo naluphi na uvavanyo olusebenzisa izilwa-buhlungu zegundane, kunokwenzeka ukuba kukho ukuphazanyiswa yi-anti-mouse antibodies (HAMA) kwi-specimen. Iisampulu ezisuka kwizigulane ezifumene amalungiselelo ee-antibodies ze-monoclonal zokuxilongwa okanye unyango zingaquka i-HAMA. Imizekelo enjalo inokubangela ubuxoki okanye iziphumo ezingalunganga.

    .Esi siphumo sovavanyo kuphela kwireferensi yeklinikhi, akufanele sisebenze njengesiseko kuphela sokuxilongwa kweklinikhi kunye nonyango, izigulane zolawulo lwezonyango kufuneka ziqwalaselwe ngokubanzi kunye neempawu zayo, imbali yonyango, ezinye iimviwo zebhubhoratri, impendulo yonyango, i-epidemiology kunye nolunye ulwazi. .
    .Le reagent isetyenziselwa kuphela iimvavanyo ze-serum kunye ne-plasma. Isenokungafumani ziphumo zichanekileyo xa isetyenziselwa ezinye iisampulu ezinje ngamathe nomchamo, njl.

    IIMPAWU ZOKUSEBENZA

    Umgca 0.5ng/mL ukuya ku-80ng/mL ukutenxa okuhambelanayo: -15% ukuya +15%.
    Umgca wolungelelwaniso i-coefficient:(r)≥0.9900
    Ukuchaneka Izinga lokubuyisela liya kuba phakathi kwe-85% - 115%.
    Ukuphindaphinda CV≤15%
    Ukuchaza ngokuthe ngqo(Akukho nanye kwizinto ezivavanyiweyo eziye zaphazamisa kuvavanyo)

    Ungenelelo

    Ukugxininiswa kokuphazamiseka

    sTnI

    1000μg/L

    cTnT

    1000μg/L

    ABP

    1000μg/L

    cTnI

    1000μg/L

    cTnC

    1000μg/L

    I-sTnT

    1000μg/L

    MYO

    1000μg/L

    RIMIZEKELO
    1.Hansen JH, et al.HAMA Ukuphazamiseka kunye ne-Murine Monoclonal Antibody-Based Immunoassays [J] .J ye-Clin Immunoassay, 1993, 16: 294-299.

    2.Levinson SS.Ubume be-Heterophilic Antibodies kunye nendima kwi-Immunoassay Interference[J].J ye-Clin Immunoassay,1992,15:108-114.

    Isitshixo kwiisimboli ezisetyenzisiweyo:

     t11-1 In Vitro Diagnostic Medical Isixhobo
     tt-2 Umenzi
     tt-71 Gcina kwi-2-30 ℃
     tt-3 Umhla WOKUPHELELWA
     tt-4 Musa Ukuphinda Usebenzise
     tt-5 ISILUMKO
     tt-6 Qhagamshelana neMiyalelo yokuSetyenziswa

    Xiamen Wiz Biotech CO.,LTD
    Idilesi: 3-4 Floor,NO.16 Building,Bio-medical Workshop,2030 Wengjiao West Road,Haicang District,361026,Xiamen,China
    Umnxeba: + 86-592-6808278
    Ifeksi: + 86-592-6808279


  • Ngaphambili:
  • Okulandelayo: